Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Percheron Therapeutics Ltd
ASX:PER
Percheron Therapeutics Ltd
ASX:PER
Price:
0.0035
AUD
-12.5%
Market Closed
Market Cap:
AU$5.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
X
|
X Bioscience PCL
SET:XBIO
|
TH |
|
Iktinos Hellas Greek Marble Industry SA
F:F40
|
GR |
|
Auburn Bancorp Inc
OTC:ABBB
|
US |
|
Coca-Cola HBC AG
F:CCKC
|
CH |
|
Bankwell Financial Group Inc
F:33W
|
US |
|
T
|
Technogym SpA
F:TN2
|
IT |
|
S
|
Savencia SA
F:BGJ
|
FR |
|
E
|
Edil San Felice SpA Societa Benefit
F:T4M
|
IT |
|
E
|
Encore Capital Group Inc
F:ECP
|
US |
|
V
|
VGI PCL
SET:VGI
|
TH |
|
C
|
Christina Lake Cannabis Corp
F:CLB
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PER's stock price target?
Not Available
PER does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Percheron Therapeutics Ltd?
Projected CAGR
517%
517%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 1 year is 517%.